Atlas Trials

Preservation and Transfer of HBV Immunity After Allogeneic HSCT for SCD

Clinical trial NCT05200338 · UNKNOWN

Trial details

NCT number
NCT05200338
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Sickle Cell Disease
Start date
2021-06-08
Primary completion
2024-01-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.